Triazole Resistance in Aspergillus fumigatus Clinical Isolates Obtained in Nanjing, China
- Author:
- No author available
- Journal Title:
- Chinese Medical Journal
- Issue:
- 6
- DOI:
- 10.4103/0366-6999.201609
- Key Word:
- Aspergillus fumigatus;cyp51A;Minimal Inhibitory Concentrations;TR34/L98H;Triazole Resistance
Abstract： Background:During the past decades,the incidence of invasive aspergillosis (IA) caused by Aspergillus fumigatus has increased dramatically.The aims of this study were to investigate the susceptibility of clinical isolates of A.fumigatus to triazole and the underlying cyp51A mutations in triazole-resistant A.fumigatus.Methods:A total of 126A.fumigatus clinical isolates from 126 patients with proven or probable IA were obtained from four large tertiary hospitals in Nanjing,China,between August 2012 and July 2015.The determination of minimal inhibitory concentrations (MICs) for itraconazole,voriconazole,and posaconazole was performed by broth microdilution according to the European Committee on Antimicrobial Susceptibility Testing reference method.Results:A total of 4 A.fumigatus isolates (3.17％) were confirmed to be itraconazole resistant,with MICs of≥8 mg/L,and one isolate (0.8％)was confirmed to be voriconazole resistant and posaconazole resistant,with MICs of 4 mg/L and 0.5 mg/L,respectively.We found that two of the 4 isolates of triazole-resistant A.fumigatus had the L98H amino acid substitution in combination with a 34-base pair tandem repeat in the promoter region,one isolate had an M220I mutation,and another itraconazole-resistant isolate did not have a substitution in the cyp51A gene.Conclusions:This study shows that triazole-resistant A.fumigatus clinical isolates are present in Nanjing,China,which is a new challenge to the clinical management of IA.
- [1]Ya-Qin Shi,PEI Li,Ting Wu,etc.Integrated Therapy for Invasive Pulmonary Aspergillosis in a Patient with Asthma and Chronic Obstructive Pulmonary Disease Overlap Syndrome[J].2015,(16).
- [2]Chowdhary,A.,Sharma,C.,Hagen,F.,etc.Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms[J].2014,9(5).
- [3]Persat F,Monier MF,Dannaoui E,etc.Acquired itraconazole resistance in Aspergillus fumigatus.[J].2001,47(3).
- [4]Denning DW,Perlin DS.Azole resistance in Aspergillus: a growing public health menace.[J].2011,6(11).
- [5]Eveline, Snelders,Simone M T, Camps,Anna, Karawajczyk,etc.Triazole fungicides can induce cross-resistance to medical triazoles in Aspergillus fumigatus.[J].2012,7(3).
- [6]Moore CB,Denning DW,Perlin DS,etc.Multi-azole resistance in Aspergillus fumigatus[J].2006,28(5).
- [7]Bader,O.,Weig,M.,Reichard,U.,etc.Cyp51A-based mechanisms of aspergillus fumigatus azole drug resistance present in clinical samples from Germany[J].2013,57(8).
- [8]Bueid A,Denning DW,Richardson MD,etc.Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009.[J].2010,65(10).
- [9]Snelders E,Melchers WJ,Verweij PE,etc.Azole resistance profile of amino acid changes in Aspergillus fumigatus CYP51A based on protein homology modeling.[J].2010,54(6).
- [10]Pfaller MA,Diekema DJ,Messer SA,etc.In Vitro Susceptibilities of Clinical Isolates of Candida Species, Cryptococcus neoformans, and Aspergillus Species to Itraconazole: Global Survey of 9,359 Isolates Tested by Clinical and Laboratory Standards Institute Broth Microdilution Methods.[J].2005,43(8).
- [11]Thomas J. Walsh.Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America[J].2008,46(3).
- [12]D W,Denning.Itraconazole resistance in Aspergillus fumigatus.[J].1997,41.
- [13]J R, Perfect,G M, Cox,J Y, Lee,etc.The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis.[J].2001,33(11).
- [14]Lockhart SR,Balajee SA,Frade JP,etc.Azole resistance in Aspergillus fumigatus isolates from the ARTEMIS global surveillance study is primarily due to the TR/L98H mutation in the cyp51A gene.[J].2011,55(9).
- [15]Pfaller MA,Diekema DJ,Ghannoum MA.Wild-type MIC distribution and epidemiological cutoff values for Aspergillus fumigatus and three triazoles as determined by the Clinical and Laboratory Standards Institute broth microdilution methods.[J].2009,47(10).
- [16]Howard, Susan J.,Cerar, Dasa,Anderson, Michael J.,etc.Frequency and Evolution of Azole Resistance in Aspergillus fumigatus Associated with Treatment Failure.[J].2009,15(7).
- [17].EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds.[J].2008,14(10).